ELENA DLUGACH: Open Payments
NPI 1740393206 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 22 payments from 9 companies in 2025. Trend: 2023 $924 · 2024 $552 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $240 |
| Teva Pharmaceuticals USA, Inc. | 8 | $194 |
| E.R. Squibb & Sons, L.L.C. | 3 | $160 |
| Alkermes, Inc. | 3 | $160 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 1 | $98 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: Auvelity, UZEDY, COBENFY, ARISTADA, FANAPT, Qelbree, CAPLYTA, REXULTI.
Industry payments across SC — which companies pay providers there.
